Nkarta, Inc. (NKTX)
NASDAQ: NKTX · Real-Time Price · USD
3.250
-0.050 (-1.52%)
At close: May 29, 2026, 4:00 PM EDT
3.200
-0.050 (-1.54%)
After-hours: May 29, 2026, 7:49 PM EDT
Nkarta Market Cap
Nkarta has a market cap or net worth of $232.52 million as of May 29, 2026. Its market cap has increased by 75.24% in one year.
Market Cap
232.52M
Enterprise Value
77.09M
1-Year Change
75.24%
Ranking
Category
Stock Price
$3.25
Market Cap Chart
Since July 10, 2020, Nkarta's market cap has decreased from $1.46B to $232.52M, a decrease of -84.12%. That is a compound annual growth rate of -26.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 232.52M | 76.95% |
| Dec 31, 2025 | 131.40M | -25.22% |
| Dec 31, 2024 | 175.72M | -45.75% |
| Dec 29, 2023 | 323.88M | 10.77% |
| Dec 30, 2022 | 292.39M | -42.19% |
| Dec 31, 2021 | 505.77M | -74.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sol-Gel Technologies | 244.55M |
| Foghorn Therapeutics | 244.25M |
| Entrada Therapeutics | 241.06M |
| Orchestra BioMed Holdings | 236.53M |
| Atrium Therapeutics | 235.54M |
| Whitehawk Therapeutics | 235.28M |
| Voyager Therapeutics | 232.62M |
| Camp4 Therapeutics | 231.07M |